GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengda Pharmaceuticals Co Ltd (SZSE:301201) » Definitions » ROCE %

Chengda Pharmaceuticals Co (SZSE:301201) ROCE % : 3.89% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Chengda Pharmaceuticals Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chengda Pharmaceuticals Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 3.89%.


Chengda Pharmaceuticals Co ROCE % Historical Data

The historical data trend for Chengda Pharmaceuticals Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengda Pharmaceuticals Co ROCE % Chart

Chengda Pharmaceuticals Co Annual Data
Trend Dec08 Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.41 36.43 23.34 8.72 4.63

Chengda Pharmaceuticals Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.14 1.77 -0.01 12.57 3.89

Chengda Pharmaceuticals Co ROCE % Calculation

Chengda Pharmaceuticals Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=104.25/( ( (2321.896 - 99.535) + (2455.325 - 171.533) )/ 2 )
=104.25/( (2222.361+2283.792)/ 2 )
=104.25/2253.0765
=4.63 %

Chengda Pharmaceuticals Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=88.188/( ( (2455.325 - 171.533) + (2403.749 - 153.321) )/ 2 )
=88.188/( ( 2283.792 + 2250.428 )/ 2 )
=88.188/2267.11
=3.89 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengda Pharmaceuticals Co  (SZSE:301201) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Chengda Pharmaceuticals Co ROCE % Related Terms

Thank you for viewing the detailed overview of Chengda Pharmaceuticals Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengda Pharmaceuticals Co (SZSE:301201) Business Description

Traded in Other Exchanges
N/A
Address
36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100
Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.

Chengda Pharmaceuticals Co (SZSE:301201) Headlines

No Headlines